Avanti Polar Lipids, now a Croda Pharma brand (Avanti Research), is a US-based manufacturer and CDMO specializing in high-purity lipids for pharmaceutical and diagnostic applications. Through Croda Alabaster, their FDA-inspected cGMP manufacturing division, they provide contract manufacturing of lipid APIs, excipients, and adjuvants for vaccines and immunotherapies. Services span from custom lipid synthesis at 25mg scale through clinical trial materials to commercial-scale bulk production (1L to 55L batches), including liposome and nanoparticle formulation in cGMP manufacturing suites. They offer lipid-based drug delivery system development, method development and validation, ICH-compliant stability testing, and full regulatory support for IND/NDA submissions.
high-purity lipid manufacturing, lipid nanoparticle (LNP) formulation, liposome production, lipid-based drug delivery, adjuvant production, cGMP lipid API and excipient synthesis
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.